The humira in ocular inflammations taper (hot) study

To assess factors that impact the risk of relapse in patients with non-infectious uveitis (NIU) who undergo adalimumab tapering after achieving remission.

Source: American Journal of Ophthalmology - September 18, 2023 Category: Opthalmology Authors: Francesco Pichi, Scott D Smith, Debra A Goldstein, Dina Baddar, Terese K A Gerges, Timothy M Janetos, Matilde Ruiz-Cruz, Luz Elena Concha-del-R ío, Kazuichi Maruyama, Josianne Carina ten Berge, Saskia M Rombach, Luca Cimino, Elena Bolletta, Elisabetta Mi Tags: Original Articles Source Type: research